| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PROVECTUS BIOPHARMACEUTICALS, INC. | 10%+ Owner | Common Stock | 12,000,000 | 12 Aug 2024 | Direct | ||
| PROVECTUS BIOPHARMACEUTICALS, INC. | 10%+ Owner | Common Stock | 6,500,000 | 12 Aug 2024 | By IRA | ||
| PROVECTUS BIOPHARMACEUTICALS, INC. | 10%+ Owner | Series D-1 Convertible Preferred Stock | 4,260,061 | 12 Aug 2024 | Direct | ||
| PROVECTUS BIOPHARMACEUTICALS, INC. | 10%+ Owner | 8% Secured Convertible Promissory Note | 244,584 | 11 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 12 Aug 2024 | 1 | +$756,467 | 4 | 10%+ Owner | 14 Aug 2024, 19:19 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 11 Aug 2023 | 1 | +$700,000 | 4 | 10%+ Owner | 14 Aug 2023, 20:07 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 08 May 2023 | 1 | +$540,223 | 4 | 10%+ Owner | 09 May 2023, 16:50 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 27 Mar 2023 | 0 | $0 | 3 | 10%+ Owner | 28 Mar 2023, 09:10 |